ArticleCancer research communications2024

mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of PIK3CA-Altered Tumors.

Constance A Sobsey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.